When a coronary artery suddenly closes, you have minutes to recognize the crisis, decode the electrical chaos on the ECG, choose between competing reperfusion strategies, and prevent lethal arrhythmias that can strike without warning. This lesson takes you from the first chest pain through the diagnostic decision tree, the time-critical treatment battlefield, and into the reconstruction phase where you'll learn to prevent remodeling and recurrent events. You'll build the pattern recognition and clinical judgment that separates competent management from mastery when seconds determine whether muscle survives or dies.

The transition from stable angina to acute MI follows a predictable sequence of cellular events, each with specific timeframes and clinical correlations:
Plaque Rupture Phase (0-15 minutes)
Thrombotic Occlusion (15-60 minutes)
📌 Remember: PLAQUE - Platelet adhesion, Lipid core exposure, Acute thrombosis, Quick occlusion, Unstable angina progression, Emergent intervention needed. Vulnerable plaques have >40% lipid content and <65 μm fibrous caps.
Understanding the temporal progression of myocardial necrosis guides all reperfusion strategies and explains the "golden hour" concept:
| Time Post-Occlusion | Cellular Changes | Reversibility | Clinical Markers | Intervention Window |
|---|---|---|---|---|
| 0-20 minutes | ATP depletion, anaerobic metabolism | 100% reversible | No biomarker elevation | Optimal reperfusion |
| 20-60 minutes | Membrane dysfunction, calcium influx | 80-90% salvageable | Minimal troponin rise | Critical window |
| 1-3 hours | Mitochondrial swelling, protein denaturation | 60-70% salvageable | Troponin elevation begins | Standard PCI window |
| 3-6 hours | Nuclear chromatin clumping, cell death | 30-40% salvageable | Peak CK-MB elevation | Extended window |
| >6 hours | Coagulation necrosis, neutrophil infiltration | <20% salvageable | Peak troponin levels | Salvage attempts |

Each coronary vessel supplies specific myocardial territories, creating predictable patterns of infarction and ECG changes:
Left Anterior Descending (LAD) - "Widow Maker"
Right Coronary Artery (RCA) - "The Rhythm Keeper"
💡 Master This: RCA dominance occurs in 85% of population, supplying PDA and posterolateral branches. In left-dominant systems (8%), LCX supplies inferior wall. Co-dominant patterns (7%) share inferior supply. This anatomy determines collateral flow patterns and infarct size - RCA occlusion in dominant systems causes larger inferior MIs with higher complication rates.
📌 Remember: INFERIOR complications - Increased bradycardia, Nausea/vomiting (vagal), Fluid retention (RV failure), Electrical blocks (AV node), Right heart involvement, Ischemic MR (posterior papillary), Occlusion patterns (RCA dominant), Rhythm disturbances. 40-50% develop bradyarrhythmias requiring atropine or pacing.
The foundation of MI pathophysiology reveals how plaque vulnerability, thrombotic occlusion, and territorial anatomy determine clinical presentation and outcomes. This cellular understanding transforms into pattern recognition frameworks that guide rapid diagnosis and optimal reperfusion strategies.

Myocardial ischemia disrupts normal electrical conduction through multiple mechanisms, each creating specific arrhythmic patterns with predictable timing:
Phase 1: Hyperacute (0-30 minutes)
Phase 2: Acute (30 minutes-12 hours)

The location of coronary occlusion determines specific conduction abnormalities based on the blood supply to specialized conduction tissues:
| Infarct Location | Conduction System Affected | Blood Supply | Incidence | Clinical Significance |
|---|---|---|---|---|
| Inferior MI | AV node, Bundle of His | RCA (90%) | 40-50% | Transient, reversible |
| Anterior MI | Bundle branches, Fascicles | LAD septal | 20-25% | Permanent, poor prognosis |
| Posterior MI | AV node (if RCA dominant) | PDA | 15-20% | Variable duration |
| Right ventricular | SA node, AV node | RCA proximal | 30-40% | Bradycardia, hypotension |
| Lateral MI | Left fascicles | LCX/OM | 10-15% | Hemiblocks |
📌 Remember: BLOCKS in MI - Bradycardia (inferior), Left bundle (anterior), Occasional pacing needs, Complete heart block, Keep atropine ready, Septal artery involvement. Anterior MI conduction blocks carry 3-fold higher mortality than inferior blocks due to extensive septal necrosis.
Early identification of high-risk patients for sudden cardiac death guides monitoring intensity and prophylactic interventions:
Highest Risk (VF/VT incidence >25%)
Moderate Risk (VF/VT incidence 10-25%)

💡 Master This: Reperfusion arrhythmias occur in 75-90% of successful thrombolysis and 60-80% of primary PCI. AIVR (rate 60-100 bpm) is benign and indicates restored flow. Sustained VT/VF during reperfusion (5-10% incidence) requires immediate defibrillation but doesn't predict future events - it's acute electrical instability, not chronic substrate.
The electrical consequences of MI create a temporal pattern of risk, where hyperacute arrhythmias threaten immediate survival while chronic conduction defects determine long-term prognosis. This understanding guides monitoring protocols and intervention thresholds throughout the acute phase.

The ECG provides real-time evidence of myocardial injury, with specific patterns that localize culprit vessels and predict complications within seconds of acquisition:
STEMI Criteria (Immediate Cath Lab Activation)
STEMI Equivalents (Treat as STEMI)

📌 Remember: ELEVATION criteria - Early recognition saves muscle, Limb leads need 1mm, V-leads need 2mm, Adjacent leads required, Time is muscle, Immediate cath lab, Occluded artery likely, New LBBB counts. False positive rate <5% when strict criteria applied with appropriate clinical context.
Cardiac biomarkers provide quantitative evidence of myocardial necrosis, with specific kinetics that guide diagnosis, prognosis, and treatment decisions:
| Biomarker | Rise Time | Peak Time | Duration | Sensitivity | Specificity | Clinical Use |
|---|---|---|---|---|---|---|
| Troponin I/T | 3-6 hours | 12-24 hours | 7-14 days | >95% | >95% | Gold standard |
| CK-MB | 4-8 hours | 12-24 hours | 2-3 days | 85-90% | 80-85% | Re-infarction |
| Myoglobin | 1-3 hours | 6-12 hours | 24 hours | >95% | <70% | Early exclusion |
| CK-Total | 6-12 hours | 18-36 hours | 3-5 days | 70-80% | <60% | Infarct sizing |
| LDH | 12-24 hours | 2-5 days | 7-14 days | 80-85% | <70% | Late diagnosis |
Successful MI diagnosis requires systematic integration of clinical presentation, ECG findings, and biomarker results within evidence-based algorithms:
STEMI Recognition (Target: <10 minutes)
NSTEMI Risk Stratification (TIMI/GRACE Scores)
💡 Master This: Type 1 MI (plaque rupture) versus Type 2 MI (supply-demand mismatch) distinction is crucial for treatment decisions. Type 2 MI shows troponin elevation but no acute plaque rupture - caused by tachycardia, hypotension, anemia, or hypoxemia. Treatment focuses on underlying cause, not antiplatelet therapy or invasive procedures.
📌 Remember: NSTEMI high-risk features - New ST depression, Sustained chest pain, Troponin markedly elevated, Elevated BNP/NT-proBNP, Mitral regurgitation murmur, Instability (hemodynamic). Early invasive strategy (<24 hours) reduces death/MI by 25% in high-risk patients.
The diagnostic framework transforms clinical uncertainty into evidence-based action, where pattern recognition and algorithmic thinking enable rapid triage and optimal resource allocation. This systematic approach ensures no STEMI goes unrecognized while avoiding unnecessary interventions in low-risk presentations.
Primary percutaneous coronary intervention represents the gold standard for STEMI reperfusion, offering superior outcomes compared to fibrinolysis when performed within evidence-based timeframes:
Primary PCI Advantages (Class I Recommendation)
Time-Dependent Efficacy (Critical Windows)

When primary PCI is unavailable or significantly delayed, fibrinolytic therapy provides effective reperfusion with specific protocols and careful patient selection:
| Agent | Dose | Administration | TIMI 3 Flow | ICH Risk | Cost |
|---|---|---|---|---|---|
| Alteplase (tPA) | 15 mg bolus + 0.75 mg/kg + 0.5 mg/kg | 90 minutes | 60-65% | 0.6-0.9% | High |
| Reteplase (rPA) | 10 U + 10 U | 30 minutes apart | 55-60% | 0.4-0.7% | Moderate |
| Tenecteplase (TNK) | Weight-based bolus | Single injection | 65-70% | 0.3-0.6% | Moderate |
| Streptokinase | 1.5 million units | 60 minutes | 45-50% | 0.3-0.5% | Low |
📌 Remember: FIBRINOLYSIS contraindications - Facial trauma/surgery, Intracranial pathology, Bleeding disorders, Recent surgery (<2 weeks), Internal bleeding, Neoplasm (CNS), Old stroke (<3 months), Labile BP (>180/110), Young age (<18), Severe liver disease, Infective endocarditis, Suspected aortic dissection.
Optimal reperfusion requires coordinated antiplatelet, anticoagulant, and supportive therapies with evidence-based dosing and monitoring protocols:
Antiplatelet Therapy (Dual Therapy Standard)
Anticoagulation Strategy (Procedure-Dependent)
💡 Master This: Prasugrel is contraindicated in patients with prior stroke/TIA and age >75 years (unless weight >60 kg and no other bleeding risks). Ticagrelor causes reversible dyspnea in 15-20% of patients due to adenosine reuptake inhibition - not dangerous but affects compliance. Genetic testing for CYP2C19 can guide clopidogrel effectiveness but results take 24-48 hours.
The reperfusion strategy selection depends on institutional capabilities, patient factors, and time constraints, where systematic protocols ensure optimal outcomes regardless of treatment modality. Success requires coordinated team effort with clear communication and evidence-based decision-making.

Post-MI ventricular remodeling follows predictable phases with specific therapeutic windows for intervention and prevention of adverse outcomes:
Acute Phase (0-72 hours)
Healing Phase (3 days-8 weeks)
Guideline-directed medical therapy forms the cornerstone of secondary prevention, with specific medications providing additive benefits for mortality reduction and event prevention:
| Medication Class | Primary Agent | Target Dose | Mortality Benefit | Key Monitoring | Contraindications |
|---|---|---|---|---|---|
| ACE Inhibitors | Lisinopril | 10-20 mg daily | 20-25% reduction | Creatinine, K+ | Bilateral RAS |
| Beta-Blockers | Metoprolol XL | 200 mg daily | 15-20% reduction | Heart rate, BP | Decompensated HF |
| Statins | Atorvastatin | 80 mg daily | 25-30% reduction | LDL, LFTs | Active hepatitis |
| Antiplatelet | Aspirin + P2Y12 | 81 mg + varies | 20-25% reduction | Bleeding signs | Active bleeding |
High-risk post-MI patients benefit from additional interventions that address specific pathophysiological mechanisms and residual cardiovascular risk:
Heart Failure Prevention (EF ≤40%)
Residual Risk Management (Recurrent Events)
💡 Master This: Cardiac rehabilitation participation reduces cardiovascular mortality by 13-20% and improves quality of life significantly. Core components include supervised exercise (3x/week for 12 weeks), nutritional counseling, smoking cessation, and psychosocial support. Participation rates remain <30% despite Class I recommendation - physician referral is the strongest predictor of enrollment.
📌 Remember: REHABILITATION benefits - Reduced mortality (15-20%), Exercise capacity improved, Heart rate recovery enhanced, Anxiety/depression decreased, Blood pressure lowered, Insulin sensitivity improved, Lipid profile optimized, Inflammation reduced, Thrombotic risk decreased, Adherence to medications increased, Tobacco cessation supported, Improved quality of life, Optimal weight management, Nutritional education provided.
The post-MI reconstruction phase requires systematic implementation of evidence-based therapies with regular monitoring and adjustment based on patient response and emerging evidence. This comprehensive approach transforms MI survivors from high-risk patients into well-managed individuals with excellent long-term prognosis.
Time-critical MI management requires standardized protocols that eliminate decision delays and ensure optimal care delivery regardless of clinical complexity or institutional resources:
| Time Frame | STEMI Actions | NSTEMI Actions | Quality Metrics | Decision Points |
|---|---|---|---|---|
| 0-10 min | ECG + IV access | ECG + troponin | Door-to-ECG <10 min | STEMI vs NSTEMI |
| 10-30 min | Cath lab activation | Risk stratification | Door-to-balloon <90 min | Primary PCI vs lysis |
| 30-60 min | Arterial access | Medical optimization | Door-to-needle <30 min | Invasive vs conservative |
| 1-6 hours | Post-PCI care | Serial biomarkers | TIMI 3 flow achieved | Complications present |
| 6-24 hours | Monitoring + meds | Cath timing decision | Guideline meds initiated | Discharge planning |
Quantitative assessment tools provide objective data for risk stratification, treatment selection, and prognosis determination:
TIMI Risk Score (STEMI)
GRACE Score (NSTEMI) - More Complex but Superior
📌 Remember: GRACE score components - Greater age increases risk, Rate (heart) elevation dangerous, Arrest (cardiac) worst prognostic sign, Creatinine elevation (renal dysfunction), Elevated troponin confirms diagnosis. Online calculators provide precise risk estimates and treatment recommendations based on individual patient factors.
Early identification of MI complications enables prompt intervention and improved outcomes through systematic surveillance and pattern recognition:
Mechanical Complications (2-7 days post-MI)
Electrical Complications (First 48 hours)
💡 Master This: Cardiogenic shock develops in 5-10% of STEMI patients with >40% mortality despite optimal therapy. Early recognition requires systematic assessment: SBP <90 mmHg, CI <2.2 L/min/m², PCWP >15 mmHg. Mechanical circulatory support (IABP, Impella, ECMO) provides bridge to recovery or definitive therapy but doesn't improve mortality unless combined with revascularization.
The MI command center approach transforms complex clinical scenarios into manageable protocols where systematic thinking, evidence-based medicine, and quality improvement converge to deliver optimal patient outcomes consistently across diverse clinical settings.
Test your understanding with these related questions
A 53-year-old man with a past medical history significant for hyperlipidemia, hypertension, and hyperhomocysteinemia presents to the emergency department complaining of 10/10 crushing, left-sided chest pain radiating down his left arm and up his neck into the left side of his jaw. His ECG shows ST-segment elevation in leads V2-V4. He is taken to the cardiac catheterization laboratory for successful balloon angioplasty and stenting of a complete blockage in his left anterior descending coronary artery. Echocardiogram the following day shows decreased left ventricular function and regional wall motion abnormalities. A follow-up echocardiogram 14 days later shows a normal ejection fraction and no regional wall motion abnormalities. This post-infarct course illustrates which of the following concepts?
Get full access to all lessons, practice questions, and more.
Start Your Free Trial